000 | 02883 a2200865 4500 | ||
---|---|---|---|
005 | 20250517125858.0 | ||
264 | 0 | _c20170613 | |
008 | 201706s 0 0 eng d | ||
022 | _a1474-5488 | ||
024 | 7 |
_a10.1016/S1470-2045(16)30559-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSwisher, Elizabeth M | |
245 | 0 | 0 |
_aRucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial. _h[electronic resource] |
260 |
_bThe Lancet. Oncology _c01 2017 |
||
300 |
_a75-87 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aBRCA1 Protein _xgenetics |
650 | 0 | 4 |
_aBRCA2 Protein _xgenetics |
650 | 0 | 4 | _aCarcinoma, Ovarian Epithelial |
650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
650 | 0 | 4 |
_aFallopian Tube Neoplasms _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aGerm-Line Mutation _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndoles _xtherapeutic use |
650 | 0 | 4 | _aInternational Agencies |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aNeoplasms, Glandular and Epithelial _xdrug therapy |
650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aPeritoneal Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aPlatinum _xpharmacology |
650 | 0 | 4 |
_aPoly(ADP-ribose) Polymerase Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aPoly(ADP-ribose) Polymerases _xchemistry |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aSalvage Therapy |
650 | 0 | 4 | _aSurvival Rate |
700 | 1 | _aLin, Kevin K | |
700 | 1 | _aOza, Amit M | |
700 | 1 | _aScott, Clare L | |
700 | 1 | _aGiordano, Heidi | |
700 | 1 | _aSun, James | |
700 | 1 | _aKonecny, Gottfried E | |
700 | 1 | _aColeman, Robert L | |
700 | 1 | _aTinker, Anna V | |
700 | 1 | _aO'Malley, David M | |
700 | 1 | _aKristeleit, Rebecca S | |
700 | 1 | _aMa, Ling | |
700 | 1 | _aBell-McGuinn, Katherine M | |
700 | 1 | _aBrenton, James D | |
700 | 1 | _aCragun, Janiel M | |
700 | 1 | _aOaknin, Ana | |
700 | 1 | _aRay-Coquard, Isabelle | |
700 | 1 | _aHarrell, Maria I | |
700 | 1 | _aMann, Elaina | |
700 | 1 | _aKaufmann, Scott H | |
700 | 1 | _aFloquet, Anne | |
700 | 1 | _aLeary, Alexandra | |
700 | 1 | _aHarding, Thomas C | |
700 | 1 | _aGoble, Sandra | |
700 | 1 | _aMaloney, Lara | |
700 | 1 | _aIsaacson, Jeff | |
700 | 1 | _aAllen, Andrew R | |
700 | 1 | _aRolfe, Lindsey | |
700 | 1 | _aYelensky, Roman | |
700 | 1 | _aRaponi, Mitch | |
700 | 1 | _aMcNeish, Iain A | |
773 | 0 |
_tThe Lancet. Oncology _gvol. 18 _gno. 1 _gp. 75-87 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1470-2045(16)30559-9 _zAvailable from publisher's website |
999 |
_c26658519 _d26658519 |